Athersys Inc (ATHXQ)

[H2R]

Hi xrhodie,

Nice find. From the Healios Web site:

1. Reason for establishment of a subsidiary
With the mission of “To be the change in an ever-evolving world through enrichment of living”,
Healios is committed to providing new therapeutic methods that bring healing and hope to
patients with refractory diseases all over the world with its excellent stem cell technologies such
as iPS cells, and through its development in the field of iPSC/somatic stem cell regenerative
medicine.
Therefore, Healios decided to establish a wholly-owned subsidiary in the United States to
implement clinical development not only in Japan but also overseas and to strengthen alliances.
2. Overview of new subsidiary
(1) N a m e Healios N.A. Inc.
(2) L o c a t i o n California, U.S.A. (tentative)
(3) R e p r e s e n t a t i ve Hardy TS Kagimoto, President
(4) B u s i n e s s Development of drugs
(5) C a p i t a l 150,000 U.S. dollars (tentative)
(6) E s t a b l i s h m e n t March 2018 (tentative)
(7) O w n e r s h i p HEALIOS K.K. 100.0%
3. Future outlook
The effect of this investment on Healios’ financial statements is not significant.
Healios keeps its sales estimate for the current term undisclosed as it considers the calculation
of proper and reasonable figures to be difficult in this situation, where there are currently a lot
of unconfirmed elements that may influence the performance, such as possible business
collaborations, acquisition of new seeds and so forth, while it will disclose its financial results
and business overview as of the end of each quarter on a timely basis.
Healios will promptly announce if there occurs any matter that must be disclosed.

For now, it looks like a first step. Treasure is the most advanced trial in the Healios pipeline, so you might be on to something.

Cheers!